Current Report · Items 5.07, 8.01, 9.01 · 8-K
MariMed Inc.
Submission of Matters to a Vote of Security Holders · Other Events
Item 5.07. Submission of Matters to Vote of Security Holders. On October 28, 2026, MariMed Inc. (the "Company") held a special meeting of stockholders (the "Special Meeting") to consider and vote on the matters listed below. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on September 22, 2026.…
Filed Oct 29, 2026Accepted Oct 29, 2026, 4:13 PM EDTCIK 1522767Accession 0001522767-26-000213
Company context
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, Vibations™, InHouse™, and Nature’s Heritage™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.
Current securities
Historical securities (2)
Disclosure sections
Items 5.07, 8.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07.
Submission of Matters to Vote of Security Holders.
On October 28, 2026, MariMed Inc. (the "Company") held a special meeting of stockholders (the "Special Meeting") to consider and vote on the matters listed below. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on September 22, 2026. At the Special Meeting, the Company's stockholders:
1. approved an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of its common stock, par value $0.001 per share (“Common Shares”), by a ratio of not less than one-for-fifty (1-for-50) and not more than one-for-one hundred (1-for-100) (the “Reverse Stock Split”), with the exact ratio to be determined by the Company’s board of directors (the “Board”) in its sole discretion (without reducing the authorized number of Common Shares) and with the Board retaining the discretion to abandon the proposed amendment and not effect the Reverse Stock Split (the “Amendment Proposal”); and
2. approved the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies in the event there were insufficient votes in favor of the Amendment Proposal (the “Adjournment Proposal”).
The specific votes were as follows:
1. The Amendment Proposal:
VOTES
FOR AGAINST ABSTAIN
219,026,236 46,400,304 221,869
2. The Adjournment Proposal:
VOTES
FOR AGAINST ABSTAIN
222,642,573 39,820,076 3,185,760
Notwithstanding stockholder approval of the Amendment Proposal, the Board has not determined whether or when to effect the Reverse Stock Split and retains the discretion to abandon the Reverse Stock Split.
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
On October 29, 2026, the Company issued a press release announcing the voting results for the Special Meeting. A copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
